The G protein-coupled estrogen receptor 1 (GPER1/GPR30) agonist G-1 regulates vascular smooth muscle cell Ca handling

Journal of Vascular Research

Volumn 50, Issue 5, 2013, Pages 421-429

  Holm, Anders ^a   Hellstrand, Per ^a   Olde, Björn ^a   Svensson, Daniel ^a   Leeb Lundberg, L M Fredrik ^a   Nilsson, Bengt Olof ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Calcium; Calcium spikes; Estrogen; Estrogen receptor; GPR30; Nifedipine; Vascular smooth muscle cells

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM CHANNEL L TYPE; ESTRADIOL; ESTROGEN RECEPTOR ANTAGONIST; G 1; G 15; G PROTEIN COUPLED RECEPTOR 30; HORMONE RECEPTOR STIMULATING AGENT; MESSENGER RNA; NIFEDIPINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM HANDLING; CALCIUM HOMEOSTASIS; CALCIUM SPIKE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ESTROGEN ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; VASCULAR SMOOTH MUSCLE CELL;

EID: 84886790262     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000354252     Document Type: Article

References (28)

1. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA: Mechanism of estrogen action. Physiol Rev 2001; 81: 1535-1565.
2. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER: A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307: 1625-1630.
3. Thomas P, Pang Y, Filardo EJ, Gong J: Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005; 146: 624-632.
4. Olde B, Leeb-Lundberg LM: GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol Metab 2009; 20: 409-416.
5. Meyer MR, Prossnitz ER, Barton M: The G protein-coupled estrogen receptor GPER/GPR30 as regulator of cardiovascular function. Vascul Pharmacol 2011; 55: 17-25.
6. Nilsson BO, Olde B, Leeb-Lundberg LM: G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling. Br J Pharmacol 2011; 163: 1131-1139.
7. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW: Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999; 103: 401-406.
8. Darblade B, Pendaries C, Krust A, Dupont S, Fouque MJ, Rami J, Chambon P, Bayard F, Arnal JF: Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res 2002; 90: 413-419.
9. Nilsson BO: Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm Res 2007; 56: 269-273.
10. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, Mendelsohn ME: Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 2002; 90: 1087-1092.
11. Pendaries C, Darblade B, Rochaix P, Krust A, Chambon P, Korach KS, Bayard F, Arnal JF: The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA 2002; 99: 2205-2210.
12. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK: Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000; 407: 538-541.
13. Toutain CE, Filipe C, Billon A, Fontaine C, Brouchet L, Guery JC, Gourdy P, Arnal JF, Lenfant F: Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization. Arterioscler Thromb Vasc Biol 2009; 29: 1543-1550.
14. Martensson UE, Salehi SA, Windahl S, Gomez MF, Sward K, Daszkiewicz-Nilsson J, Wendt A, Andersson N, Hellstrand P, Grande PO, Owman C, Rosen CJ, Adamo ML, Lundquist I, Rorsman P, Nilsson BO, Ohlsson C, Olde B, Leeb-Lundberg LM: Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiolstimulated insulin release in female mice. Endocrinology 2009; 150: 687-698.
15. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, Gao X, Mueller-Guerre L, Marjon NA, Gut A, Minotti R, Meyer MR, Amann K, Ammann E, Perez-Dominguez A, Genoni M, Clegg DJ, Dun NJ, Resta TC, Prossnitz ER, Barton M: Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 2009; 104: 288-291.
16. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC: Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 2009; 150: 3753-3758.
17. Broughton BR, Miller AA, Sobey CG: Endothelium-dependent relaxation by G proteincoupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol 2010; 298:H1055-H1061.
18. Holm A, Baldetorp B, Olde B, Leeb-Lundberg LM, Nilsson BO: The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J Vasc Res 2011; 48: 327-335.
19. Berridge MJ, Lipp P, Bootman MD: The versatility and universality of calcium signaling. Nat Rev Cell Biol 2000; 1: 11-21.
20. Haddock RE, Hill CE: Rhythmicity in arterial smooth muscle. J Physiol 2005; 566: 645-656.
21. Bolton TB: Calcium events in smooth muscles and their interstitial cells; physiological roles of sparks. J Physiol 2006; 570: 5-11.
22. Byron KL, Taylor CW: Spontaneous Ca 2+ spiking in a vascular smooth muscle cell line is independent of the release of intracellular Ca 2+ stores. J Biol Chem 1993; 268: 6945-6952.
23. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45.
24. Cornil CA, Ball GF, Balthazart J: Functional significance of rapid regulation of brain estrogen action: where do the estrogens come from? Brain Res 2006; 1126: 2-26.
25. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER: Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2006; 2: 207-212.
26. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leilao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER: In vivo effects of a GPR30 antagonist. Nat Chem Biol 2009; 5: 421-427.
27. Mani BK, Brueggemann LI, Cribbs LL, Byron KL: Opposite regulation of KCNQ5 and TRPC6 channels contributes to vasopressinstimulated calcium spiking responses in A7r5 vascular smooth muscle cells. Cell Calcium 2009; 45: 400-411.
28. Zhang F, Ram JL, Standley PR, Sowers JR: 17 Estradiol attenuates voltage-dependent Ca 2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol 1994; 266:C975-C980.